个人简介

Dr. Paul M. Hassoun is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pulmonary disease and critical care medicine. Dr. Hassoun serves as the director of the Pulmonary Hypertension Program. He earned his M.D. from Faculte de Medecine Lariborsiere. He completed his residency at Brigham and Women's Hospital and performed a fellowship at Massachusetts General Hospital and at New England Medical Center Hospitals. Dr. Hassoun's research interests include acute lung injury, regulation and role of xanthine oxidase in lung injury, and molecular determinants of pulmonary hypertension. He was recognized by the Department of Medicine with a Levine Excellence in Mentoring Award in 2008. He is a member of numerous professional organizations, including the American Heart Association, the American Thoracic Society and the European Respiratory Society. MD, Faculte' de Medecine Lariborsiere - (1981)

研究领域

Acute lung injury; Regulation and role of xanthine oxidase in lung injury; Molecular determinants of pulmonary hypertension; Pulmonary hypertension/Scleroderma-associated pulmonary hypertension

Dr. Hassoun is directing a research program investigating the cause and treatment of pulmonary arterial hypertension in scleroderma.

近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Al-Naamani N, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Shimbo D, Post WS, Kawut SM; ASA-STAT Study Group. "Prognostic significance of biomarkers in pulmonary arterial hypertension." Ann Am Thorac Soc. 2015 Oct 26. [Epub ahead of print] Mathai SC, Suber T, Khair RM, Kolb TM, Damico RL, Hassoun PM. "Health-related quality of life and survival in pulmonary arterial hypertension." Ann Am Thorac Soc. 2015 Oct 22. [Epub ahead of print] Gao L, Emond MJ, Louie T, Cheadle C, Berger AE, Rafaels N, Vergara C, Kim Y, Taub MA, Ruczinski I, Mathai SC, Rich SS, Nickerson DA, Hummers LK, Bamshad MJ, Hassoun PM, Mathias RA; National Heart, Lung, and Blood Institute (NHLBI) GO Exome Sequencing Project, Barnes KC. "Whole-exome sequencing identifies rare variants in ATP8B4 as a risk factor for systemic sclerosis." Arthritis Rheumatol. 2015 Oct 16. doi: 10.1002/art.39449. [Epub ahead of print] Corona-Villalobos CP, Kamel IR, Rastegar N, Damico R, Kolb TM, Boyce DM, Sager AE, Skrok J, Shehata ML, Vogel-Claussen J, Bluemke DA, Girgis RE, Mathai SC, Hassoun PM, Zimmerman SL. "Bidimensional measurements of right ventricular function for prediction of survival in patients with pulmonary hypertension: comparison of reproducibility and time of analysis with volumetric cardiac magnetic resonance imaging analysis." Pulm Circ. 2015 Sep;5(3):527-37. doi: 10.1086/682229. Fallica J, Varela L, Johnston L, Kim B, Serebreni L, Wang L, Damarla M, Kolb TM, Hassoun PM, Damico R. "Macrophage migration inhibitory factor (MIF) is a novel inhibitor of ASK1-p38-XOR-dependent cigarette smoke-induced apoptosis." Am J Respir Cell Mol Biol. 2015 Sep 21. [Epub ahead of print] Damarla M, Parniani AR, Johnston L, Maredia H, Serebreni L, Hamdan O, Sidhaye VK, Shimoda LA, Myers AC, Crow MT, Schmidt EP, Machamer CE, Gaestel M, Rane MJ, Kolb TM, Kim BS, Damico RL, Hassoun PM. MK2 Mediates Apoptosis During Lung Vascular Permeability by Regulating Movement of Cleaved Caspase 3. Am J Respir Cell Mol Biol. 2013 Dec 4. [Epub ahead of print] PMID: 24304496 Nathan SD, Hassoun PM. Pulmonary Hypertension due to Lung Disease and/or Hypoxia. Clin Chest Med. 2013 Dec;34(4):695-705. doi: 10.1016/j.ccm.2013.08.004. Epub 2013 Oct 17. PMID: 24267299 [PubMed - in process] Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013 Oct;144(4):1346-56. doi: 10.1378/chest.12-2396. PMID: 24081346 [PubMed - in process] Tedford RJ, Mudd JO, Girgis RE, Mathai SC, Zaiman AL, Housten-Harris T, Boyce D, Kelemen BW, Bacher AC, Shah AA, Hummers LK, Wigley FM, Russell SD, Saggar R, Saggar R, Maughan WL, Hassoun PM, Kass DA. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail. 2013 Sep 1;6(5):953-63. PMID: 23797369 Hassoun PM, Shafiq M. Tackling the challenges of systemic sclerosis-associated pulmonary hypertension: one step forward. Arthritis Rheum. 2013 Sep;65(9):2240-2. doi: 10.1002/art.38031. No abstract available. PMID: 23740649 Hassoun PM, Nikkho S, Rosenzweig EB, Moreschi G, Lawrence J, Teeter J, Meier C, Ghofrani AH, Minai O, Rinaldi P, Michelakis E, Oudiz RJ. Updating clinical endpoint definitions. Pulm Circ. 2013 Jan;3(1):206-16. doi: 10.4103/2045-8932.109920. PMID: 23662199 Hoeper MM, Barst RJ, Bourge RC, Feldman J, Frost AE, Galié N, Gómez-Sánchez MA, Grimminger F, Grunig E, Hassoun PM, Morrell NW, Peacock AJ, Satoh T, Simonneau G, Tapson VF, Torres F, Lawrence D, Quinn DA, Ghofrani HA. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation. 2013 Mar 12;127(10):1128-38. doi: 10.1161/CIRCULATIONAHA.112.000765. Epub 2013 Feb 12. PMID: 23403476 Mathai SC, Hassoun PM. Drs. Mathai and Hassoun reply. J Rheumatol. 2013 Jan;40(1):91. No abstract available. PMID: 23401876 Kim BS, Serebreni L, Hamdan O, Wang L, Parniani A, Sussan T, Scott Stephens R, Boyer L, Damarla M, Hassoun PM, Damico R. Xanthine oxidoreductase is a critical mediator of cigarette smoke-induced endothelial cell DNA damage and apoptosis. Free Radic Biol Med. 2013 Jul;60:336-46. doi: 10.1016/j.freeradbiomed.2013.01.023. Epub 2013 Feb 4. PMID: 23380026 Shehata ML, Harouni AA, Skrok J, Basha TA, Boyce D, Lechtzin N, Mathai SC, Girgis R, Osman NF, Lima JA, Bluemke DA, Hassoun PM, Vogel-Claussen J. Regional and global biventricular function in pulmonary arterial hypertension: a cardiac MR imaging study. Radiology. 2013 Jan;266(1):114-22. doi: 10.1148/radiol.12111599. Epub 2012 Nov 14. PMID: 23151825